Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions.
about
Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multicentric survey on dose re ...... f suspected adverse reactions.
@en
Multicentric survey on dose re ...... f suspected adverse reactions.
@nl
type
label
Multicentric survey on dose re ...... f suspected adverse reactions.
@en
Multicentric survey on dose re ...... f suspected adverse reactions.
@nl
prefLabel
Multicentric survey on dose re ...... f suspected adverse reactions.
@en
Multicentric survey on dose re ...... f suspected adverse reactions.
@nl
P2093
P2860
P50
P356
P1433
P1476
Multicentric survey on dose re ...... f suspected adverse reactions.
@en
P2093
Antonio Maugeri
Carla Masini
Dino Amadori
Emanuela Scarpi
Erica Bianchini
Giovanni Luca Frassineti
Maria Laura Gallani
Martina Minguzzi
Martina Valgiusti
Silvia Menozzi
P2860
P304
40719-40724
P356
10.18632/ONCOTARGET.8942
P407
P577
2016-04-22T00:00:00Z